Nexentis Technologies (NXTS) Cost of Revenue (2019 - 2025)
Nexentis Technologies' Cost of Revenue came in at $2,000 for Q3 2025, down 97.4% from $77,000 a year earlier and unchanged from the prior quarter.
Nexentis Technologies (NXTS) Cost of Revenue (2019 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Nexentis Technologies reported Cost of Revenue of $73,000, down 23.8% year-over-year; for FY2024, it came in at $165,000, up 200.0% from FY2023.
- Cost of Revenue carries a five-year compound annual growth rate of 2.7% (FY2019 to FY2024).
- Going back by year, Cost of Revenue was $55,000 in FY2023 (-65.3%), $158,313 in FY2022 (+16.5%), $135,943 in FY2021 (+213.2%) and $43,405 in FY2020 (-70.0%).
- The five-year range for quarterly Cost of Revenue is -$15,229 (Q4 2023) to $79,064 (Q4 2022).
- Year-over-year, Cost of Revenue has declined for three consecutive quarters, with an average decline of 65.3% over the last five quarters.
- The fastest year-over-year change in Cost of Revenue over five years came in Q4 2021 (growth of 283.8%), and the weakest in Q3 2023 (a decline of 98.0%).
- Business Quant data shows NXTS's Cost of Revenue at $2,000 (Q2 2025), $14,000 (Q1 2025) and $55,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Nexentis Technologies | 1.18 Mn | -21.59 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | -15,229.00 |
| Sep 30, 2023 | 476.00 |
| Jun 30, 2023 | 27,007.00 |
| Mar 31, 2023 | 42,746.00 |
| Dec 31, 2022 | 79,064.00 |
| Sep 30, 2022 | 24,402.00 |
| Jun 30, 2022 | 12,998.00 |
| Mar 31, 2022 | 41,849.00 |
| Dec 31, 2021 | 68,012.00 |
| Sep 30, 2021 | 53,644.00 |
| Jun 30, 2021 | 11,354.00 |
| Mar 31, 2021 | 2,933.00 |
| Dec 31, 2020 | 17,719.00 |
Nexentis Technologies Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NXTS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();